Order Article Reprints

Lai C-C, Chen C-H, Chen K-H, Wang C-Y, Huang T-M, Wang Y-H, Wang H-C. The Impact of 52-Week Single Inhaler Device Triple Therapy versus Dual Therapy on the Mortality of COPD Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Life. 2022; 12(2):173. https://doi.org/10.3390/life12020173

Lai, Chih-Cheng, Chao-Hsien Chen, Kuang-Hung Chen, Cheng-Yi Wang, Tsan-Ming Huang, Ya-Hui Wang, and Hao-Chien Wang. 2022. "The Impact of 52-Week Single Inhaler Device Triple Therapy versus Dual Therapy on the Mortality of COPD Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials" Life 12, no. 2: 173. https://doi.org/10.3390/life12020173

Lai, C.-C., Chen, C.-H., Chen, K.-H., Wang, C.-Y., Huang, T.-M., Wang, Y.-H., & Wang, H.-C. (2022). The Impact of 52-Week Single Inhaler Device Triple Therapy versus Dual Therapy on the Mortality of COPD Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Life, 12(2), 173. https://doi.org/10.3390/life12020173